查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1986650

體外診斷市場規模、佔有率和趨勢分析報告：按產品、最終用途、技術、檢測地點、應用、地區和細分市場預測（2026-2033 年）

In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents), By End Use (Hospitals, Laboratory), By Technology, By Test Location, By Application, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 320 Pages | 商品交期: 2-10個工作天內

價格

體外診斷市場概述

全球體外診斷市場預計到 2025 年價值 1,062.9 億美元，預計到 2033 年將達到 1,281.8 億美元。

預計從 2026 年到 2033 年，該市場將以 2.40% 的複合年成長率成長。這一市場成長是由全球對準確、快速和個人化診斷解決方案的需求不斷成長所驅動的。

市場成長的關鍵促進因素包括慢性病和感染疾病病率的上升、診斷技術的進步以及以價值為導向的醫療保健模式的轉變，這種模式強調早期檢測和預防醫學。將數位健康、人工智慧和數據分析整合到診斷平台中，可以提高檢測準確性和臨床決策水準。此外，就地檢驗和個人化醫療的普及，加上新興市場的成長和疫情防範能力的提升，正在持續推動市場滲透，並為相關人員創造重要的商業機會。預計在預測期內，慢性病、感染疾病以及阿茲海默症、透納氏症和帕金森氏症等遺傳性疾病盛行率的上升將進一步推動市場需求。

根據美國疾病管制與預防中心（CDC）的數據，癌症、糖尿病等慢性疾病以及慢性腎臟病和氣喘等呼吸道疾病，占美國每年死亡人數的70%。大約十分之六的美國成年人可能患有慢性疾病。這些慢性疾病每年造成美國醫療保健系統4.1兆美元的損失。 2024年，美國確診病例62萬例，死亡213例，主要集中在美洲，其中巴西、巴拉圭和阿根廷的病例負擔最重。亞洲確診病例較多，尤其是印度和巴基斯坦，塞內加爾是非洲唯一出現感染病例的國家。歐洲方面，法國報告了一例本土傳播病例，法屬留尼旺島旺島通報了118例。

預計在準確性、成本效益和便攜性方面的技術進步將成為該市場的主要驅動力。領先的市場參與企業正檢測套組線。各公司加大研發投入和合作項目也推動了創新產品的上市。小型化、奈米技術、微流體和雲端連接的即時診斷技術的進步，使得分子層面的診斷更加經濟實惠、易於使用且更加靈敏。配備多種生物感測平台的智慧型手機連接讀取器可實現即時現場診斷。 3D列印技術提高了即時診斷設備的製造流程和性能，而具備無線通訊功能的軟性感測器則可實現對患者的即時監測，從而應用於預防醫學和感染疾病疫情應對。這些創新表明，即時分子診斷技術取得了顯著進展，並展現了對醫療保健的潛在影響。

預計用於感染疾病診斷臨床研究的外部資金增加將推動市場成長，因為資金對於推進產品開發至關重要。例如，2025年1月，羅德島醫院從CARB-X獲得100萬美元的津貼，用於支持開發一種直接針對肺炎致病菌的血液PCR檢測方法，旨在改善下呼吸道感染疾病（LRTI）的診斷。這項研發滿足了感染疾病分子診斷市場對快速且準確診斷的迫切需求，有助於對抗抗藥性並改善患者照護。

然而，分子檢測的高昂成本是限制該市場成長的主要因素之一。缺乏可比產品是造成價格高昂的另一個原因。不同分子診斷產品的價格差異顯著，進一步加劇了這個問題。此外，分子診斷設備的高成本仍是市場成長的一大挑戰。例如，Bio-Rad Laboratories 的 CFX Connect PCR 檢測系統售價約為 17,995 美元，而 Thermo Fisher Scientific 的 7900 HT qPCR 系統售價在 20,000 美元至 30,000 美元之間。數位 PCR (dPCR) 儀器具有更高的準確性和靈敏度，但價格甚至高於即時PCR系統。手動 dPCR 儀器的價格通常在 65,000 美元至 70,000 美元之間，而自動化 dPCR 系統的價格可能超過 100,000 美元。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：體外診斷市場的影響因素、趨勢與範圍

  • 市場歷史及展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
  • 體外診斷市場分析工具
    • 波特的分析
    • PESTEL 分析
  • 體外診斷試劑與實驗室自建檢測報銷概述
  • 價格分析

第4章：體外診斷市場：依產品分類的估算與趨勢分析

  • 體外診斷市場：產品特定波動分析（2025 年和 2033 年）
  • 裝置
  • 試劑
  • 服務

第5章：體外診斷市場：依技術分類的估算與趨勢分析

  • 體外診斷市場：基於技術的波動分析，2025 年和 2033 年
  • 免疫檢測
    • 裝置
    • 試劑
    • 服務
  • 血液學
    • 裝置
    • 試劑
    • 服務
  • 臨床化學
    • 裝置
    • 試劑
    • 服務
  • 分子診斷
    • 裝置
    • 試劑
    • 服務
  • 凝血
    • 裝置
    • 試劑
    • 服務
  • 微生物學
    • 裝置
    • 試劑
    • 服務
  • 其他
    • 裝置
    • 試劑
    • 服務

第6章：體外診斷市場：按應用分類的估算與趨勢分析

  • 體外診斷市場：基於應用領域的波動分析，2025 年和 2033 年
  • 感染疾病
  • 糖尿病
  • 腫瘤學/癌症
  • 循環系統
  • 腎臟病學
  • 自體免疫疾病
  • 藥物檢測
  • 其他

第7章 體外診斷市場：依檢測地點分類的估算與趨勢分析

  • 體外診斷市場：按檢測地點分類的波動分析（2025 年和 2033 年）
  • 照護現場
  • 居家照護
  • 其他

第8章：體外診斷市場：依最終用途分類的估算與趨勢分析

  • 體外診斷市場：依最終用途分類的波動分析（2025 年和 2033 年）
  • 醫院
  • 檢查室
  • 居家醫療
  • 其他

第9章：體外診斷市場：區域估算與趨勢分析

  • 體外診斷市場：區域佔有率（2025 年和 2033 年）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 丹麥
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 科威特

第10章 競爭格局

  • 主要市場參與企業近期趨勢及影響分析
  • 公司分類
  • 全球企業市場占有率分析（2025 年）
  • 企業熱力圖分析
  • 策略規劃
    • 業務拓展
    • 併購
    • 夥伴關係和聯盟
    • 新產品發布
    • 研究與開發
  • 公司簡介
    • Abbott
    • Bio-Rad Laboratories, Inc
    • Siemens Healthineers AG
    • BIOMERIEUX
    • BD
    • QIAGEN
    • Quidel Corporation
    • F. Hoffmann-La Roche Ltd.
    • Danaher
    • Quest Diagnostics Incorporated
    • Agilent Technologies, Inc.
Product Code: 978-1-68038-080-4

In Vitro Diagnostics Market Summary

The global in vitro diagnostics market size was estimated at USD 106.29 billion in 2025 and is projected to reach USD 128.18 billion by 2033, growing at a CAGR of 2.40% from 2026 to 2033. This market growth is attributed to the rising global demand for accurate, rapid, and personalized diagnostic solutions.

Some of the key growth factors driving the market growth include the increasing prevalence of chronic and infectious diseases, advancements in diagnostic technologies, and the shift toward value-based healthcare emphasizing early detection and preventive care. The integration of digital health, AI, and data analytics into diagnostic platforms enhances test accuracy and clinical decision-making. In addition, the expansion of point-of-care testing, personalized medicine, and emerging markets, coupled with heightened pandemic preparedness, continues to drive market penetration, creating significant opportunities for industry stakeholders. The increase in the prevalence of chronic & infectious diseases and genetic disorders, such as Alzheimer's disease, Turner syndrome, & Parkinson's disease, is expected to boost the market demand during the forecast period.

According to the CDC, chronic diseases such as cancer & diabetes, and chronic kidney & respiratory diseases, such as asthma, are responsible for 7 in 10 deaths in the U.S. each year. Around 6 out of 10 adults are likely to suffer from a chronic disease in the U.S. These chronic diseases account for USD 4.1 trillion in annual healthcare costs in the U.S. In 2024, 620,000 cases and 213 deaths were detected, primarily in the Americas, with Brazil, Paraguay, and Argentina reporting the highest burdens. Asia saw significant cases, particularly in India and Pakistan, while Senegal was the only affected African country. Europe recorded one locally acquired case in France and 118 cases in La Reunion.

Technological advancements in terms of accuracy, cost-effectiveness, and portability are expected to be among the high-impact rendering drivers for this market. Leading market participants are updating their range of testing options by undertaking R&D initiatives for the development of kits that target life-threatening conditions or by entering into collaborations with other kit manufacturing players. Innovative product launches in the market are also a result of the rising number of R&D and partnership programs by players. Advancements in miniaturization, nanotechnology, microfluidics, and cloud-connected POC diagnostics are making molecular-level diagnostics more affordable, user-friendly, and sensitive. Smartphone-integrated readers with diverse biosensing platforms enable onsite and on-time diagnoses. 3D printing enhances POC device fabrication and performance, while flexible sensors with wireless communication allow real-time patient monitoring for preventative healthcare and disease outbreaks. These innovations signify significant progress in POC molecular diagnostics and its potential impact on healthcare.

The increase in external funding for clinical studies in infectious disease molecular diagnostics is expected to drive market growth, as funding is crucial in advancing product development. For example, in January 2025, Rhode Island Hospital received a USD 1 million grant from CARB-X to support the development of a direct-from-blood PCR test for pneumonia-causing bacteria, aiming to improve diagnostics for lower respiratory tract infections (LRTIs). This advancement addresses the urgent need for rapid, accurate diagnostics to combat antibiotic resistance and enhance patient care in the infectious disease molecular diagnostics market.

However, high prices associated with molecular tests are one of the major factors impeding this market. Lack of comparable products is another reason for the hiked prices. The significant price variations for different applications of each molecular diagnostic product further compound this problem. Moreover, the high cost of molecular diagnostic instruments remains a key challenge for market growth. For example, Bio-Rad Laboratories' CFX Connect PCR Detection System is priced at approximately USD 17,995, while Thermo Fisher Scientific's 7900 HT qPCR system ranges between USD 20,000 and USD 30,000. Digital PCR (dPCR) instruments offer greater accuracy and sensitivity and are even more expensive than real-time PCR systems. Manual dPCR instruments typically cost between USD 65,000 and USD 70,000, whereas automated dPCR systems can exceed USD 100,000.

Global In Vitro Diagnostics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global in vitro diagnostics market report based on products, technology, application, test location, end use, and region.

  • Product Outlook (Revenue, USD Billion, 2021 - 2033) (Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Instruments
  • Reagents
  • Services
  • Technology Outlook (Revenue, USD Billion, 2021 - 2033) (Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Immunoassay
    • Instruments
    • Reagents
    • Services
  • Hematology
    • Instruments
    • Reagents
    • Services
  • Clinical Chemistry
    • Instruments
    • Reagents
    • Services
  • Molecular Diagnostics
    • Instruments
    • Reagents
    • Services
  • Coagulation
    • Instruments
    • Reagents
    • Services
  • Microbiology
    • Instruments
    • Reagents
    • Services
  • Others
    • Instruments
    • Reagents
    • Services
  • Application Outlook (Revenue, USD Billion, 2021 - 2033) (Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Infectious Diseases
  • Diabetes
  • Oncology
  • Cardiology
  • Nephrology
  • Autoimmune Diseases
  • Drug Testing
  • Other applications
  • Test Location Outlook (Revenue, USD Billion, 2021 - 2033) (Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Point of Care
  • Home-care
  • Services
  • End Use Outlook (Revenue, USD Billion, 2021 - 2033) (Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Hospitals
  • Laboratory
  • Home Care
  • Others
  • Regional Outlook (Revenue, USD Billion, 2021 - 2033) (Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product
    • 1.2.2. Technology
    • 1.2.3. Application
    • 1.2.4. Test Location
    • 1.2.5. End Use
  • 1.3. Regional Scope
  • 1.4. Estimates and Forecast Timeline
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
  • 1.7. Details of primary research
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity flow analysis (Model 1)
      • 1.9.1.1. Approach 1: Commodity flow approach
    • 1.9.2. Volume price analysis (Model 2)
      • 1.9.2.1. Approach 2: Volume price analysis
  • 1.10. Research Scope and Assumptions
    • 1.10.1. List of Secondary Sources
    • 1.10.2. List of Primary Sources
    • 1.10.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. In Vitro Diagnostics Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Introduction of Technologically Advanced Products
      • 3.2.1.2. Increasing Demand for PoC Testing
      • 3.2.1.3. Growing Prevalence of Target Diseases
      • 3.2.1.4. Increasing External Funding for R&D
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Presence of Ambiguous Regulatory Framework
      • 3.2.2.2. High Capital Investment
      • 3.2.2.3. High Prices of Molecular Diagnostic Tests
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Supply Chain Analysis
    • 3.2.5. Distribution Channel
      • 3.2.5.1. Direct Sales
      • 3.2.5.2. Distributors Network
      • 3.2.5.3. E-commerce and Online Platforms
      • 3.2.5.4. Major Distributors
  • 3.3. In Vitro Diagnostics Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Legal landscape
  • 3.4. Reimbursement Overview of IVDs and LDTs
  • 3.5. Pricing Analysis

Chapter 4. In Vitro Diagnostics Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. In Vitro Diagnostics Market: Product Movement Analysis, USD Billion, 2025 & 2033
  • 4.3. Instruments
    • 4.3.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.4. Reagents
    • 4.4.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.5. Services
    • 4.5.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 5. In Vitro Diagnostics Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. In Vitro Diagnostics Market: Technology Movement Analysis, USD Billion, 2025 & 2033
  • 5.3. Immunoassay
    • 5.3.1. Immunoassay Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 5.3.2. Instruments
      • 5.3.2.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Units)
    • 5.3.3. Reagents
      • 5.3.3.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Reagents, Number of Tests in Million)
    • 5.3.4. Services
      • 5.3.4.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 5.4. Hematology
    • 5.4.1. Hematology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 5.4.2. Instruments
      • 5.4.2.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands)
    • 5.4.3. Reagents
      • 5.4.3.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Reagents, Number of Tests in Million)
    • 5.4.4. Services
      • 5.4.4.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 5.5. Clinical Chemistry
    • 5.5.1. Clinical Chemistry Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 5.5.2. Instruments
      • 5.5.2.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands)
    • 5.5.3. Reagents
      • 5.5.3.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Reagents, Number of Tests in Million)
    • 5.5.4. Services
      • 5.5.4.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 5.6. Molecular Diagnostics
    • 5.6.1. Molecular Diagnostics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 5.6.2. Instruments
      • 5.6.2.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands)
    • 5.6.3. Reagents
      • 5.6.3.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Reagents, Number of Tests in Million)
    • 5.6.4. Services
      • 5.6.4.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 5.7. Coagulation
    • 5.7.1. Coagulation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 5.7.2. Instruments
      • 5.7.2.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands)
    • 5.7.3. Reagents
      • 5.7.3.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Reagents, Number of Tests in Million)
    • 5.7.4. Services
      • 5.7.4.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 5.8. Microbiology
    • 5.8.1. Microbiology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 5.8.2. Instruments
      • 5.8.2.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands)
    • 5.8.3. Reagents
      • 5.8.3.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Reagents, Number of Tests in Million)
    • 5.8.4. Services
      • 5.8.4.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 5.9. Others
    • 5.9.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 5.9.2. Instruments
      • 5.9.2.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands)
    • 5.9.3. Reagents
      • 5.9.3.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Reagents, Number of Tests in Million)
    • 5.9.4. Services
      • 5.9.4.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 6. In Vitro Diagnostics Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. In Vitro Diagnostics Market: Application Movement Analysis, USD Billion, 2025 & 2033
  • 6.3. Infectious Disease
    • 6.3.1. Infectious Disease Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 6.4. Diabetes
    • 6.4.1. Diabetes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 6.5. Oncology/Cancer
    • 6.5.1. Oncology/Cancer Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 6.6. Cardiology
    • 6.6.1. Cardiology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 6.7. Nephrology
    • 6.7.1. Nephrology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 6.8. Autoimmune Diseases
    • 6.8.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 6.9. Drug Testing
    • 6.9.1. Drug Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 6.10. Others
    • 6.10.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 7. In Vitro Diagnostics Market: Test Location Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. In Vitro Diagnostics Market: Test Location Movement Analysis, USD Billion, 2025 & 2033
  • 7.3. Point of Care
    • 7.3.1. Point of Care Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.4. Home-care
    • 7.4.1. Home-care Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.5. Others
    • 7.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 8. In Vitro Diagnostics Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. In Vitro Diagnostics Market: End Use Movement Analysis, USD Billion, 2025 & 2033
  • 8.3. Hospitals
    • 8.3.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
  • 8.4. Laboratory
    • 8.4.1. Laboratory Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
  • 8.5. Home Care
    • 8.5.1. Home Care Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
  • 8.6. Others
    • 8.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)

Chapter 9. In Vitro Diagnostics Market: Regional Estimates & Trend Analysis

  • 9.1. In Vitro Diagnostics Market Share, By Region, 2025 & 2033, USD Billion
  • 9.2. North America
    • 9.2.1. North America In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.2.2. U.S.
      • 9.2.2.1. Key Country Dynamics
      • 9.2.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.2.2.3. Competitive Insights
      • 9.2.2.4. U.S. In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.2.3. Canada
      • 9.2.3.1. Key Country Dynamics
      • 9.2.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.2.3.3. Competitive Insights
      • 9.2.3.4. Canada In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.2.4. Mexico
      • 9.2.4.1. Key Country Dynamics
      • 9.2.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.2.4.3. Competitive Insights
      • 9.2.4.4. Mexico In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
  • 9.3. Europe
    • 9.3.1. Europe In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.2. U.K.
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.2.3. Competitive Insights
      • 9.3.2.4. U.K. In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.3. Germany
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.3.3. Competitive Insights
      • 9.3.3.4. Germany In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.4. France
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.4.3. Competitive Insights
      • 9.3.4.4. France In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.5. Italy
      • 9.3.5.1. Key Country Dynamics
      • 9.3.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.5.3. Competitive Insights
      • 9.3.5.4. Italy In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.6. Spain
      • 9.3.6.1. Key Country Dynamics
      • 9.3.6.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.6.3. Competitive Insights
      • 9.3.6.4. Spain In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.7. Sweden
      • 9.3.7.1. Key Country Dynamics
      • 9.3.7.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.7.3. Competitive Insights
      • 9.3.7.4. Sweden In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.8. Denmark
      • 9.3.8.1. Key Country Dynamics
      • 9.3.8.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.8.3. Competitive Insights
      • 9.3.8.4. Denmark In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.9. Norway
      • 9.3.9.1. Key Country Dynamics
      • 9.3.9.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.9.3. Competitive Insights
      • 9.3.9.4. Norway In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 9.4.2. China
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.2.3. Competitive Insights
      • 9.4.2.4. China In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.4.3. Japan
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.3.3. Competitive Insights
      • 9.4.3.4. Japan In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.4.4. India
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.4.3. Competitive Insights
      • 9.4.4.4. India In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.4.5. South Korea
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.5.3. Competitive Insights
      • 9.4.5.4. South Korea In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.4.6. Australia
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.6.3. Competitive Insights
      • 9.4.6.4. Australia In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.4.7. Thailand
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.7.3. Competitive Insights
      • 9.4.7.4. Thailand In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
  • 9.5. Latin America
    • 9.5.1. Latin America In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.5.2.3. Competitive Insights
      • 9.5.2.4. Brazil In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.5.3. Argentina
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.5.3.3. Competitive Insights
      • 9.5.3.4. Argentina In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Middle East and Africa In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.6.2. Saudi Arabia
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.2.3. Competitive Insights
      • 9.6.2.4. Saudi Arabia In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.6.3. UAE
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.3.3. Competitive Insights
      • 9.6.3.4. UAE In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.6.4. South Africa
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.4.3. Competitive Insights
      • 9.6.4.4. South Africa In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.6.5. Kuwait
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.5.3. Competitive Insights
      • 9.6.5.4. Kuwait In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis by Key Market Participants
  • 10.2. Company Categorization
  • 10.3. Global Company Market Share Analysis, 2025
  • 10.4. Company Heat Map Analysis
  • 10.5. Strategy Mapping
    • 10.5.1. Expansion
    • 10.5.2. Mergers & Acquisition
    • 10.5.3. Partnerships & Collaborations
    • 10.5.4. New Product Launches
    • 10.5.5. Research And Development
  • 10.6. Company Profiles
    • 10.6.1. Abbott
      • 10.6.1.1. Participant's Overview
      • 10.6.1.2. Financial Performance
      • 10.6.1.3. Product Benchmarking
      • 10.6.1.4. Recent Developments
    • 10.6.2. Bio-Rad Laboratories, Inc
      • 10.6.2.1. Participant's Overview
      • 10.6.2.2. Financial Performance
      • 10.6.2.3. Product Benchmarking
      • 10.6.2.4. Recent Developments
    • 10.6.3. Siemens Healthineers AG
      • 10.6.3.1. Participant's Overview
      • 10.6.3.2. Financial Performance
      • 10.6.3.3. Product Benchmarking
      • 10.6.3.4. Recent Developments
    • 10.6.4. BIOMERIEUX
      • 10.6.4.1. Participant's Overview
      • 10.6.4.2. Financial Performance
      • 10.6.4.3. Product Benchmarking
      • 10.6.4.4. Recent Developments
    • 10.6.5. BD
      • 10.6.5.1. Participant's Overview
      • 10.6.5.2. Financial Performance
      • 10.6.5.3. Product Benchmarking
      • 10.6.5.4. Recent Developments
    • 10.6.6. QIAGEN
      • 10.6.6.1. Participant's Overview
      • 10.6.6.2. Financial Performance
      • 10.6.6.3. Product Benchmarking
      • 10.6.6.4. Recent Developments
    • 10.6.7. Quidel Corporation
      • 10.6.7.1. Participant's Overview
      • 10.6.7.2. Financial Performance
      • 10.6.7.3. Product Benchmarking
      • 10.6.7.4. Recent Developments
    • 10.6.8. F. Hoffmann-La Roche Ltd.
      • 10.6.8.1. Participant's Overview
      • 10.6.8.2. Financial Performance
      • 10.6.8.3. Product Benchmarking
      • 10.6.8.4. Recent Developments
    • 10.6.9. Danaher
      • 10.6.9.1. Participant's Overview
      • 10.6.9.2. Financial Performance
      • 10.6.9.3. Product Benchmarking
      • 10.6.9.4. Recent Developments
    • 10.6.10. Quest Diagnostics Incorporated
      • 10.6.10.1. Participant's Overview
      • 10.6.10.2. Financial Performance
      • 10.6.10.3. Product Benchmarking
      • 10.6.10.4. Recent Developments
    • 10.6.11. Agilent Technologies, Inc.
      • 10.6.11.1. Participant's Overview
      • 10.6.11.2. Financial Performance
      • 10.6.11.3. Product Benchmarking
      • 10.6.11.4. Recent Developments

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Regulatory Framework
  • Table 4 Global In Vitro Diagnostics Market, By Region, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 5 Global In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 6 Global In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 7 Global In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 8 Global In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 9 Global In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 10 North America In Vitro Diagnostics Market, By Country, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 11 North America In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 12 North America In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 13 North America In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 14 North America In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 15 North America In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 16 U.S. In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 17 U.S. In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 18 U.S. In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 19 U.S. In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 20 U.S. In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 21 Canada In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 22 Canada In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 23 Canada In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 24 Canada In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 25 Canada In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 26 Mexico In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 27 Mexico In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 28 Mexico In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 29 Mexico In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 30 Mexico In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 31 Europe In Vitro Diagnostics Market, By Country, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 32 Europe In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 33 Europe In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 34 Europe In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 35 Europe In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 36 Europe In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 37 U.K. In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 38 U.K. In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 39 U.K. In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 40 U.K. In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 41 U.K. In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 42 Germany In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 43 Germany In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 44 Germany In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 45 Germany America In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 46 Germany In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 47 France In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 48 France In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 49 France In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 50 France In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 51 France In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 52 Spain In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 53 Spain In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 54 Spain In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 55 Spain In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 56 Spain In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 57 Italy In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 58 Italy In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 59 Italy In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 60 Italy In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 61 Italy In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 62 Asia Pacific In Vitro Diagnostics Market, By Country, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 63 Asia Pacific In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 64 Asia Pacific In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 65 Asia Pacific In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 66 Asia Pacific In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 67 Asia-Pacific In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 68 China In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 69 China In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 70 China In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 71 China In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 72 China In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 73 Japan In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 74 Japan In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 75 Japan In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 76 Japan In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 77 Japan In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 78 India In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 79 India In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 80 India In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 81 India In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 82 India In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 83 South Korea In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 84 South Korea In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 85 South Korea In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 86 South Korea In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 87 South Korea In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 88 Australia In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 89 Australia In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 90 Australia In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 91 Australia In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 92 Australia In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 93 Latin America In Vitro Diagnostics Market, By Country, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 94 Latin America In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 95 Latin America In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 96 Latin America In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 97 Latin America In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 98 Latin America In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 99 Brazil In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 100 Brazil In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 101 Brazil In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 102 Brazil In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 103 Brazil In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 104 Argentina In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 105 Argentina In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 106 Argentina In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 107 Argentina In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 108 Argentina In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 109 MEA In Vitro Diagnostics Market, By Country, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 110 MEA In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 111 MEA In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 112 MEA In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 113 MEA In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 114 MEA In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 115 South Africa In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 116 South Africa In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 117 South Africa In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 118 South Africa In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 119 UAE In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 120 UAE In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 121 UAE In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 122 UAE In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 123 UAE In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 124 UAE In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion million
  • Table 125 Saudi Arabia In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 126 Saudi Arabia In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 127 Saudi Arabia In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 128 Saudi Arabia In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 129 Saudi Arabia In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 130 Kuwait In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 131 Kuwait In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 132 Kuwait In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 133 Kuwait In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 134 Kuwait In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion

List of Figures

  • Fig. 1 In Vitro Diagnostics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 In vitro diagnostics market snapshot
  • Fig. 10 Parent market outlook, 2025
  • Fig. 11 In vitro diagnostics market driver impact
  • Fig. 12 Global elderly population
  • Fig. 13 New cancer cases by year
  • Fig. 14 In vitro diagnostics market restraint impact
  • Fig. 15 Market entry strategy
  • Fig. 16 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 IVD market: Product outlook and key takeaways
  • Fig. 19 IVD market: Products movement analysis
  • Fig. 20 Instruments market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 21 Reagents market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 22 Services market estimates and forecast, 2021 - 2033 USD billion
  • Fig. 23 IVD market: Technology outlook and key takeaways
  • Fig. 24 IVD Market: Technology movement analysis
  • Fig. 25 Immunoassay market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 26 Instruments market for immunoassay estimates and forecast, 2021 - 2033 USD billion, volume, number of instruments, in thousands
  • Fig. 27 Reagents market for immunoassay estimates and forecast, 2021 - 2033 USD billion, volume, reagents, number of tests in million
  • Fig. 28 Services market for immunoassay estimates and forecast, 2021 - 2033 USD billion
  • Fig. 29 Hematology market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 30 Instruments market for hematology estimates and forecast, 2021 - 2033 USD billion, volume, number of instruments, in thousands
  • Fig. 31 Reagents market for hematology estimates and forecast, 2021 - 2033 USD billion, volume, reagents, number of tests in million
  • Fig. 32 Services market for hematology estimates and forecast, 2021 - 2033 USD billion
  • Fig. 33 Clinical chemistry market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 34 Instruments market for clinical chemistry estimates and forecast, 2021 - 2033 USD billion, volume, number of instruments, in thousands
  • Fig. 35 Reagents market for clinical chemistry estimates and forecast, 2021 - 2033 USD billion, volume, reagents, number of tests in million
  • Fig. 36 Services market for clinical chemistry estimates and forecast, 2021 - 2033 USD billion
  • Fig. 37 Molecular diagnostics market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 38 Instruments market for molecular diagnostics estimates and forecast, 2021 - 2033 USD billion, volume, number of instruments, in thousands
  • Fig. 39 Reagents market for molecular diagnostics estimates and forecast, 2021 - 2033 USD billion, volume, reagents, number of tests in million
  • Fig. 40 Services market for molecular diagnostics estimates and forecast, 2021 - 2033 USD billion
  • Fig. 41 Coagulation market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 42 Instruments market for coagulation estimates and forecast, 2021 - 2033 USD billion, volume, number of instruments, in thousands
  • Fig. 43 Reagents market for coagulation estimates and forecast, 2021 - 2033 USD billion, volume, reagents, number of tests in million
  • Fig. 44 Services market for coagulation estimates and forecast, 2021 - 2033 USD billion
  • Fig. 45 Microbiology market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 46 Instruments market for microbiology estimates and forecast, 2021 - 2033 USD billion, volume, number of instruments, in thousands
  • Fig. 47 Reagents market for microbiology estimates and forecast, 2021 - 2033 USD billion, volume, reagents, number of tests in million
  • Fig. 48 Services market for microbiology estimates and forecast, 2021 - 2033 USD billion
  • Fig. 49 Others market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 50 Instruments market estimates and forecast, 2021 - 2033 USD billion, volume, number of instruments, in thousands
  • Fig. 51 Reagents market estimates and forecast, 2021 - 2033 USD billion, volume, reagents, number of tests in million
  • Fig. 52 Services market for other technology estimates and forecast, 2021 - 2033 USD billion
  • Fig. 53 IVD market: Application outlook and key takeaways
  • Fig. 54 IVD market: Application movement analysis
  • Fig. 55 Infectious diseases market estimates and forecast, 2021 - 2033 USD billion
  • Fig. 56 Diabetes market estimates and forecast, 2021 - 2033 USD billion
  • Fig. 57 Oncology market estimates and forecast, 2021 - 2033 USD billion
  • Fig. 58 Cardiology market estimates and forecast, 2021 - 2033 USD billion
  • Fig. 59 Nephrology market estimates and forecast, 2021 - 2033 USD billion
  • Fig. 60 Autoimmune diseases market estimates and forecast, 2021 - 2033 USD billion
  • Fig. 61 Drug testing market estimates and forecast, 2021 - 2033 USD billion
  • Fig. 62 Others market estimates and forecast, 2021 - 2033 USD billion
  • Fig. 63 IVD market: End-use outlook and key takeaways
  • Fig. 64 IVD treatment market: End-use movement analysis
  • Fig. 65 Hospitals market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 66 Laboratory market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 67 Home care market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 68 Other market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 69 IVD market: test location outlook and key takeaways
  • Fig. 70 IVD treatment market: Test location movement analysis
  • Fig. 71 Point-of-care market estimates and forecast, 2021 - 2033 USD billion
  • Fig. 72 Homecare market estimates and forecast, 2021 - 2033 USD billion
  • Fig. 73 Others market estimates and forecast, 2021 - 2033 USD billion
  • Fig. 74 IVD Market: Regional outlook and key takeaways
  • Fig. 75 IVD market: Regional movement analysis
  • Fig. 76 North America
  • Fig. 77 North America. market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 78 U.S. key country dynamics
  • Fig. 79 U.S. market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 80 Canada key country dynamics
  • Fig. 81 Canada market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 82 Mexico key country dynamics
  • Fig. 83 Mexico market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 84 Europe
  • Fig. 85 Europe market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 86 U.K. key country dynamics
  • Fig. 87 UK market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 88 Germany key country dynamics
  • Fig. 89 Germany market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 90 Spain key country dynamics
  • Fig. 91 Spain market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 92 France key country dynamics
  • Fig. 93 France market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 94 Italy key country dynamics
  • Fig. 95 Italy market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 96 Denmark key country dynamics
  • Fig. 97 Denmark market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 98 Sweden key country dynamics
  • Fig. 99 Sweden market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 100 Norway key country dynamics
  • Fig. 101 Norway market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 102 Asia Pacific
  • Fig. 103 Asia Pacific market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 104 Japan key country dynamics
  • Fig. 105 Japan market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 106 China key country dynamics
  • Fig. 107 China. market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 108 India key country dynamics
  • Fig. 109 India. market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 110 South Korea key country dynamics
  • Fig. 111 South Korea market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 112 Thailand key country dynamics
  • Fig. 113 Thailand market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 114 Australia key country dynamics
  • Fig. 115 Australia market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 116 Latin America
  • Fig. 117 Latin America market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 118 Brazil key country dynamics
  • Fig. 119 Brazil market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 120 Argentina key country dynamics
  • Fig. 121 Argentina market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 122 MEA
  • Fig. 123 MEA market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 124 South Africa key country dynamics
  • Fig. 125 South Africa market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 126 UAE key country dynamics
  • Fig. 127 UAE market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 128 Saudi Arabia key country dynamics
  • Fig. 129 Saudi Arabia market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 130 Kuwait key country dynamics
  • Fig. 131 Kuwait market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)